HDAC-IN-71
Based on 1 publication(s) in Google Scholar
HDAC-IN-71 (Compound 17q) is a potent HDAC inhibitor with IC50 values of 12.6, 14.1, 20, 3, and 72 nM for HDAC1, HDAC2, HDAC3, HDAC6, and HDAC10, respectively. HDAC-IN-71 induces apoptosis and can be used in cancer research.
For research use only. We do not sell to patients.
- CAS No.: 2995354-52-2
- Formula: C19H24N2O5
- Molecular Weight:360.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) HDAC-IN-71
More
Biological Activity
Description
IC50 & Target
|
HDAC1 12.6 nM (IC50) |
HDAC2 14.1 nM (IC50) |
HDAC3 20 nM (IC50) |
HDAC6 3 nM (IC50) |
HDAC10 72 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
1.39 μM
Compound: 17q
|
Antiproliferative activity against human A549 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human A549 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| DU-145 | IC50 |
0.16 μM
Compound: 17q
|
Antiproliferative activity against human DU-145 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human DU-145 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| HCT-116 | IC50 |
0.47 μM
Compound: 17q
|
Antiproliferative activity against human HCT-116 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| HT-29 | IC50 |
1.05 μM
Compound: 17q
|
Antiproliferative activity against human HT-29 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human HT-29 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| LNCaP | IC50 |
0.63 μM
Compound: 17q
|
Antiproliferative activity against human LNCaP cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human LNCaP cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| MCF7 | IC50 |
0.35 μM
Compound: 17q
|
Antiproliferative activity against human MCF7 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human MCF7 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| MDA-MB-231 | IC50 |
0.31 μM
Compound: 17q
|
Antiproliferative activity against human MDA-MB-231 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| NCI-H1650 | IC50 |
3.56 μM
Compound: 17q
|
Antiproliferative activity against human NCI-H1650 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human NCI-H1650 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| NCI-H446 | IC50 |
0.65 μM
Compound: 17q
|
Antiproliferative activity against human NCI-H446 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human NCI-H446 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
| PC-3 | IC50 |
0.72 μM
Compound: 17q
|
Antiproliferative activity against human PC-3 cells incubated for 96 hrs by MTT assay
Antiproliferative activity against human PC-3 cells incubated for 96 hrs by MTT assay
|
[PMID: 38503167] |
In Vitro
HDAC-IN-71 (0-1.6 μM; 24 h) inhibits colony formation in a dose-dependent manner and completely inhibits colony formation of DU145 cells at a concentration of 3.2 μM[1].
HDAC-IN-71 (0-1.6 μM; 72 h) arrests cells in G2/M phase and induces apoptosis in DU145 cell line in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:DU145 cells
-
Concentration:0, 0.2, 0.4, 0.8, 1.6 μM
-
Incubation Time:12 h
-
Result:Inhibited cancer cell migration.
-
Cell Line:DU145 cells
-
Concentration:0, 0.2, 0.4, 0.8, 1.6 μM
-
Incubation Time:72 h
-
Result:Arrested cells in G2/M phase in a dose-dependent manner.
-
Cell Line:DU145 cells
-
Concentration:0.8, 1.6, 3.2 μM
-
Incubation Time:24 h
-
Result:Induced histone acetylation and inhibited HDAC6 expression.
In Vivo
Pharmacokinetic analysis[1]
| Parameters | I.V. (2 mg/kg) | P.O. (10 mg/kg) |
| AUC0-∞ (h ng/mL) | 1633.35 | 3799.46 |
| T1/2 (h) | 3.12 | 2.87 |
| CL (L/h/kg) | 1.57 | |
| V (L/kg) | 4.63 | |
| Cmax(ng/mL) | 851.5 | 774.0 |
| F | 46.52% |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c nude mice[1]
-
Dosage:100, 200 mg/kg
-
Administration:Oral administration; daily; 40 days
-
Result:Significantly inhibited prostate cancer (PCa) tumor growth.
Chemical Information
-
CAS No. 2995354-52-2
-
Molecular Weight 360.40
-
Formula C19H24N2O5
-
SMILES
COC1=C(C=CC=C1)/C=C2CC(N(C\2=O)CCCCCCC(NO)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Protocols
-
Detection of Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)